Article 2U.K.
1.The importation into [F1Great Britain] of tiered-priced products for the purposes of release for free circulation, [F2export], [F3or a special Customs procedure] shall be prohibited.
2.The following shall be exempted from the prohibition regarding tiered-priced products as set out in paragraph 1:
(a)[F4export of the tiered-priced products] to countries of destination;
(b)placing under a transit or [F5storage procedure] for the purpose of [F6export of the tiered-priced products] to a country of destination.
[F73.In this Article—
(a)‘special Customs procedure’ has the meaning given by section 3(4) of the Taxation (Cross-border Trade) Act 2018;
(b)‘storage procedure’ has the meaning given by paragraph 2(1) of Schedule 2 to the Taxation (Cross-border Trade) Act 2018.]
Textual Amendments
F1Words in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(i)
F2Word in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(ii)
F3Words in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(iii)
F4Words in Art. 2(2)(a) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(i)
F5Words in Art. 2(2)(b) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(ii)
F6Words in Art. 2(2)(b) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(i)
F7Art. 2(3) inserted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(c)